February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral artery disease (PAD) and prevent lower limb amputations. The company announced the expansion of its national footprint with the opening of an office in Richmond, Texas. The company will also soon be opening clinics in Indianapolis, Houston, St. Louis and Kansas City. 

Figure 1: Picture of the Emblem S-ICD Subcutaneous Electrode with an arrow showing where separation usually happens (distal to the proximal sense ring).

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific Emblem S-ICD subcutaneous electrode as a Class I recall.

February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current state of cardiac data management, recently emerged from stealth mode to announce the launch of CaRM, the company’s unique cloud-based software that streamlines patient data from multiple electrophysiology (EP) cardiac devices onto one accessible and easy-to-use platform. 

February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis, said a recent Medicare reimbursement rate reduction for long-term electrocardiogram (ECG) monitoring is a big set back for patient care.

The rates published by Medicare Administrative Contractor (MAC) Novitas Solutions for CPT codes 93241, 93243, 93245, and 93247 showed up to a 74% reduction in physician reimbursements, Cardiac Insight said. 

February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small relative decrease in cardiovascular mortality among middle-aged adults. The study was published this week in the Journal of the American Medical Association (JAMA).


February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2021. This is based on the website’s record 726,770 pageviews for the month. 

1. iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction

January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA) system to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy.

January 29, 2020 — North America’s medical devices industry saw a drop of 17.3% in overall deal activity during the fourth quarter of 2020, when compared to the four-quarter average, according to the healthcare market research firm GlobalData.

A total of 220 deals worth $16.93 billion were announced for the region during Q4 2020, against the last four-quarter average of 266 deals.

Of all the deal types, venture financing saw most activity in Q4 2020 with 127, representing a 57.7% share for the region.

Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 

In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. 

But while this pandemic will end at some point, it is quite unlikely that we will completely eradicate the novel coronavirus that causes COVID-19 (SARS-CoV-2) — the way we did, for instance, with the virus that causes smallpox.

January 27, 2021 — Philips Healthcare has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to the current standard of care for managing AAA patients. Based on 3-D ultrasound, Philips AAA Model delivers clinicians accurate diagnostic information without exposing patients to high doses of radiation and nephrotoxic contrast agents.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now